These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 17720959)

  • 21. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
    Ikpa PT; Doktorova M; Meijsen KF; Nieuwenhuijze NDA; Verkade HJ; Jonker JW; de Jonge HR; Bijvelds MJC
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):47-60. PubMed ID: 31470114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids.
    Bramlett KS; Yao S; Burris TP
    Mol Genet Metab; 2000 Dec; 71(4):609-15. PubMed ID: 11136553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity.
    Zhang Z; Du Z; Liu Q; Wu T; Tang Q; Zhang J; Huang C; Huang Y; Li R; Li Y; Zhao Y; Zhang G; Zhou J; Huang H; Fang Z; He J
    Metabolism; 2021 May; 118():154728. PubMed ID: 33581130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
    Zollner G; Wagner M; Moustafa T; Fickert P; Silbert D; Gumhold J; Fuchsbichler A; Halilbasic E; Denk H; Marschall HU; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G923-32. PubMed ID: 16357057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.
    Li T; Matozel M; Boehme S; Kong B; Nilsson LM; Guo G; Ellis E; Chiang JY
    Hepatology; 2011 Mar; 53(3):996-1006. PubMed ID: 21319191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis.
    Inagaki T; Choi M; Moschetta A; Peng L; Cummins CL; McDonald JG; Luo G; Jones SA; Goodwin B; Richardson JA; Gerard RD; Repa JJ; Mangelsdorf DJ; Kliewer SA
    Cell Metab; 2005 Oct; 2(4):217-25. PubMed ID: 16213224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP.
    Davis RA; Miyake JH; Hui TY; Spann NJ
    J Lipid Res; 2002 Apr; 43(4):533-43. PubMed ID: 11907135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sterol 12α-Hydroxylase Aggravates Dyslipidemia by Activating the Ceramide/mTORC1/SREBP-1C Pathway via FGF21 and FGF15.
    Pathak P; Chiang JYL
    Gene Expr; 2019 Nov; 19(3):161-173. PubMed ID: 30890204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
    Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
    Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
    Duan Y; Zhang F; Yuan W; Wei Y; Wei M; Zhou Y; Yang Y; Chang Y; Wu X
    Life Sci; 2019 Sep; 232():116638. PubMed ID: 31288013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes.
    Miao J; Choi SE; Seok SM; Yang L; Zuercher WJ; Xu Y; Willson TM; Xu HE; Kemper JK
    Mol Endocrinol; 2011 Jul; 25(7):1159-69. PubMed ID: 21566081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
    Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
    Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ileum-liver Farnesoid X Receptor signaling axis mediates the compensatory mechanism of 17α-ethynylestradiol-induced cholestasis via increasing hepatic biosynthesis of chenodeoxycholic acids in rats.
    Zhang F; Xi L; Duan Y; Qin H; Wei M; Wu Y; Li B; Zhou Y; Wu X
    Eur J Pharm Sci; 2018 Oct; 123():404-415. PubMed ID: 30077711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional specificities of Brm and Brg-1 Swi/Snf ATPases in the feedback regulation of hepatic bile acid biosynthesis.
    Miao J; Fang S; Lee J; Comstock C; Knudsen KE; Kemper JK
    Mol Cell Biol; 2009 Dec; 29(23):6170-81. PubMed ID: 19805516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.
    Goodwin B; Jones SA; Price RR; Watson MA; McKee DD; Moore LB; Galardi C; Wilson JG; Lewis MC; Roth ME; Maloney PR; Willson TM; Kliewer SA
    Mol Cell; 2000 Sep; 6(3):517-26. PubMed ID: 11030332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficiency of Both Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Exacerbated Liver Fibrosis in Mice.
    Ferrell JM; Pathak P; Boehme S; Gilliland T; Chiang JYL
    Hepatology; 2019 Sep; 70(3):955-970. PubMed ID: 30664797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling.
    Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Morretta E; Monti MC; Distrutti E; Fiorucci S
    FASEB J; 2022 Jan; 36(1):e22060. PubMed ID: 34862975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Removal of the bile acid pool upregulates cholesterol 7alpha-hydroxylase by deactivating FXR in rabbits.
    Xu G; Pan LX; Erickson SK; Forman BM; Shneider BL; Ananthanarayanan M; Li X; Shefer S; Balasubramanian N; Ma L; Asaoka H; Lear SR; Nguyen LB; Dussault I; Suchy FJ; Tint GS; Salen G
    J Lipid Res; 2002 Jan; 43(1):45-50. PubMed ID: 11792721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal farnesoid X receptor signaling controls hepatic fatty acid oxidation.
    Lu D; Liu Y; Luo Y; Zhao J; Feng C; Xue L; Xu J; Wang Q; Yan T; Xiao P; Krausz KW; Gonzalez FJ; Xie C
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Feb; 1867(2):159089. PubMed ID: 34856412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism.
    Lan T; Rao A; Haywood J; Kock ND; Dawson PA
    J Hepatol; 2012 Aug; 57(2):359-65. PubMed ID: 22542490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.